255
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Acceptability of self-collected human papillomavirus specimens as a primary screen for cervical cancer

, &
Pages 87-91 | Published online: 20 Dec 2011

References

  • Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC. 2005. Acceptability of self-collection of specimens for HPV DNA Testing in an urban population. Journal of Women's Health 14:721–730.
  • Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D . 2003. Management of women who test positive for high-risk types of human papillomavirus: The HART study. Lancet 362:1871–1876.
  • DeAlba I, Anton-Culver H, Hubbell A, Ziogas A., Hess JR, Bracho A . 2008. Self-sampling for human papillomavirus in a community setting: Feasibility in Hispanic women. Cancer Epidemiology Biomarkers and Prevention 17:2163–2168.
  • Dzuba IG, Diaz EY, Allen B, Leonard YF, Ponce ECL, Shah KV . 2002. The acceptability of self-collected samples for HPV testing vs. the Pap test as alternatives in cervical cancer screening. Journal of Women's Health and Gender-Based Medicine 11:265–274.
  • Flores Y, Bishai D, Lazcano E, Shah K, Lorincz A, Hernandez M . 2003. Improving cervical cancer screening in Mexico: Results from the Morelos HPV study. Salud Publica Mexicana 45:S388–S398.
  • Flores Y, Shah K, Lazcano EC, Hernández M, Bishai D, Ferris D . 2002. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study. Salud Publica Mexicana 44:335–344.
  • Goldie SJ, Gaffikin L, Goldhaber-Fiebert AB, Gordillo-Tobar A, Levin C, Mahe C . 2005. Cost-effectiveness of cervical-cancer screening in five developing countries. New England Journal of Medicine 353:2158–2168.
  • Kahn JA, Bernstein DI, Rosenthal SL, Huang B, Kollar LM, Colyer JL . 2005. Acceptability of human papillomavirus self testing in female adolescents. Sexually Transmitted Infections 81:408–414.
  • Khanna N, Mishra SI, Tian G, Tan MT, Arnold S, Lee C . 2007. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. International Journal of Gynecologic Cancer 17:615–622.
  • Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. 2000. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. Journal of the National Cancer Institute 92:818–825.
  • Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM . 2002. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities. Journal of the American Medical Association 288:1749–1757.
  • Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A . 2007. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. New England Journal Medicine 357:1579–1588.
  • Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jeronimo J . 2008. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 26S:L37–L48.
  • Ogilvie G, Krajden M, Maginley J, Isaac-Renton J, Hislop G, Elwood-Martin R . 2007. Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women. Canadian Medical Association Journal 177:480–483.
  • Pereira SM, Castelo A, Makabe S, Utagawa ML, DiLoreto C, Maeda MY . 2005. Screening for cervical cancer in high-risk populations: DNA Pap test or Hybrid Capture II test alone? International Journal Gynecologic Pathology 25:38–41.
  • Ronco G, Giorgi-Rossi P, Carozzi F, Palma PD, Del Mistro A, De Marco L . 2006. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: Results at recruitment for a randomised controlled trial. Lancet Oncology 7:547–555.
  • Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A . 2008. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. Journal of the National Cancer Institute 100:492–501.
  • Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A . 2010. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomized controlled trial. Lancet Oncology 11:249–257.
  • Salmeron J, Lazcano-Ponce E, Lorincz A, Hernandez M, Hernandez P, Leyva A . 2003. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 14:505–512.
  • Sankaranarayanan R, Nene B, Shastri SS, Jayant K, Muwonge R, Budukh AM . 2009. HPV screening for cervical cancer in rural India. New England Journal of Medicine 360:1385–1394.
  • Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S . 2000. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. Journal of the American Medical Association 283:87–93.
  • Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P . 2000. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. Canadian Medical Association Journal 163:513–518.
  • Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J . 2007. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. Journal of Medical Screening 14:34–42.
  • WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Nicaragua. 2009. Summary Report 2009. Geneva, Switzerland: World Health Organization Document Production Services. Available at: www.who.int/hpvcentre (Accessed: 27 October 2009).
  • WHO. 2007. Cervical cancer, human papillomavirus (HPV), and HPV vaccines: Key points for policy-makers and health professionals. Geneva, Switzerland: World Health Organization Document Production Services. Available at: http://www.who.int/reproductive-health/publications/cervical_cancer_keypoints/cerv_cancer_hpv_keypts.pdf (Accessed 2 May 2009).
  • Wikstrom I, Stenvall H, Wilander E. 2007. Attitudes to self-sampling of vaginal smear for human papillomavirus analysis among women not attending organized cytological screening. Acta Obstetrica Gynecologica 86:720–725.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.